Code | 4424D | ||||||||||
MA number | EU/1/20/1431/001 | ||||||||||
Product Form: | con inf 1x10 ml/100 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Pfizer Europe MA EEIG, Belgium | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(4) similar biological application |
MA issued: | 01.04.2020 |
Validity: | 01.04.2025 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 14.12.2022 |